Emolecules Acquires Frontier Scientific Inc. And Frontier Agricultural Sciences Inc.

Company

About

eMolecules was founded in 2005 with a vision to reduce drug discovery timelines through improved efficiencies in the compound search and acquisition process. This led to the creation of the industry's most powerful, reliable and accurate digital chemical search engine directly connecting chemists to the world's largest readily available chemical space. eMolecules specializes in unique structures with dependable delivery options coming from a trusted network of hundreds of suppliers, globally. With an extensive chemical database combined with industry-leading supply chain management, eMolecules delivers compounds quickly and reliably to chemists enabling the completion of more syntheses with more confidence and less time in the lab. eMolecules remains the primary global purchasing channel for chemical building blocks and screening compounds at 13 of the top 15 pharmaceutical companies. Continued commitment to supporting drug discovery research has led to the expansion of eMolecules' services to providing chemical intelligence data, specialty reagent procurement services and providing integrated eCommerce software for chemical building blocks, screening compounds, and primary antibody supply chains.With nearly 60 employees globally, eMolecules is headquartered in San Diego, California, USA and has laboratory space and offices in California, USA and London, UK. Avista Capital Partners, a private equity firm, became the primary investors of eMolecules in 2021.